Skip to main content

AdaptHealth Corp.

corporate_fare Company Profile

AdaptHealth Corp.

AHCO·NASDAQ·Industrial Applications And Services·CIK 0001725255

AdaptHealth Corp. is a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies, and related services. The company operates through four reportable segments. The Sleep Health segment provides sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services, for obstructive sleep apnea. The Respiratory Health segment offers oxygen and home mechanical ventilation equipment and supplies, along with chronic therapy services, for respiratory diseases like chronic obstructive pulmonary disease and chronic respiratory failure. The Diabetes Health segment provides medical devices, including continuous glucose monitors and insulin pumps, and related services for diabetes treatment. The Wellness at Home segment delivers home medical equipment and services to patients in their homes, including those discharged from acute care and other facilities, providing essential medical supplies and durable medical equipment for patients adjusting to new lifestyles or managing complex disease states. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors. As of December 31, 2025, AdaptHealth serviced approximately 4.3 million patients annually across all 50 states through its network of approximately 640 locations in 48 states. The company delivers products directly to a patient's home upon discharge from a hospital or receipt of a physician/medical referral.

AdaptHealth Corp. (NASDAQ:AHCO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors AHCO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • AdaptHealth Reports Wider Q1 Loss, Negative Free Cash Flow Amid Debt Refinancing and Regulatory Headwinds
  • AdaptHealth Reports Mixed Q1 Results, Raises Revenue Guidance, and Announces COO Transition
  • AdaptHealth Projects FY26 Revenue Between $3.45B and $3.52B
  • AdaptHealth to Elect Declassified Board, Details Executive Compensation with Strong Pay-for-Performance Alignment
  • AdaptHealth Secures $1.1 Billion Senior Secured Credit Facility, Extending Maturity and Reducing Debt Costs

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.24B
Net Income
-$70.79M
Diluted EPS
-$0.52
Op. Cash Flow
$601.77M
Free Cash Flow
$219.38M
Gross Profit
$609.2M
Operating Income
$90.87M
Cash & Equivalents
$106.14M
Total Debt
$1.74B
Debt / Equity
1.14×
Net Margin
-2.2%
Shares Outstanding
135.45M sh
Source: 10-K · filed 2026-02-24 · accession 0001628280-26-011213
Browse all tickers starting with A →
$10.16
52-week range · as of 2026-05-05 $7.95 – $13.43
Market cap
$1.38B
Volume
769.5K (0.5× avg)
3-mo avg 1.4M
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AHCO - Latest Insights

AHCO
May 05, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.75
Real-time Price: $10.16 info
Change: -$1.59 (-14%) info
Market Cap: $1.382B info
AHCO
May 05, 2026, 7:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.40
Real-time Price: $10.16 info
Change: -$2.24 (-18%) info
Market Cap: $1.382B info
AHCO
May 05, 2026, 7:07 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.51
Real-time Price: $10.16 info
Change: -$2.35 (-19%) info
Market Cap: $1.382B info
AHCO
Apr 28, 2026, 4:33 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $13.38
Real-time Price: $10.16 info
Change: -$3.22 (-24%) info
Market Cap: $1.382B info
AHCO
Apr 13, 2026, 8:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.15
Real-time Price: $10.16 info
Change: -$1.99 (-16%) info
Market Cap: $1.382B info
AHCO
Mar 23, 2026, 6:25 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $10.37
Real-time Price: $10.16 info
Change: -$0.210 (-2%) info
Market Cap: $1.382B info
AHCO
Mar 12, 2026, 9:10 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $9.75
Real-time Price: $10.16 info
Change: +$0.410 (+4%) info
Market Cap: $1.382B info
AHCO
Feb 24, 2026, 5:09 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $8.86
Real-time Price: $10.16 info
Change: +$1.30 (+15%) info
Market Cap: $1.382B info
AHCO
Feb 24, 2026, 7:11 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.37
Real-time Price: $10.16 info
Change: -$0.210 (-2%) info
Market Cap: $1.382B info